Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukaemia (Acute)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01147939
What this trial is testing

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)
Clavis Pharma 381
Testing effectiveness (Phase 2)Ended earlyNCT03176277
What this trial is testing

ONO-7475 in Patients With Acute Leukemias

Who this might be right for
Acute LeukemiaMyelodysplastic Syndromes
Ono Pharmaceutical Co., Ltd. 42
Very early researchWithdrawnNCT07338357
What this trial is testing

Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML

Who this might be right for
AML (Acute Myeloid Leukemia)CAR-T
First Affiliated Hospital of Guangxi Medical University
Large-scale testing (Phase 3)Study completedNCT02393859
What this trial is testing

Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Leukemia, Acute Lymphoblastic
Amgen 111
Not applicableStudy completedNCT05236296
What this trial is testing

Emotion and Symptom-focused Engagement for Caregivers (EASE-CG) Pilot Study

Who this might be right for
Leukemia, Acute
University Health Network, Toronto 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03876769
What this trial is testing

Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 121
Not applicableEnded earlyNCT04858594
What this trial is testing

Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy

Who this might be right for
Acute Myeloid Leukemia
Masonic Cancer Center, University of Minnesota 3
Not applicableStudy completedNCT02891551
What this trial is testing

An Observational Post Authorisation Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the Netherlands

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute
Celgene 209
Not applicableStudy completedNCT00386373
What this trial is testing

Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 10
Early research (Phase 1)Ended earlyNCT04250051
What this trial is testing

Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRecurrent Myelodysplastic SyndromeRecurrent Myeloproliferative Neoplasm+5 more
Northwestern University 2
Early research (Phase 1)Looking for participantsNCT05188170
What this trial is testing

Niclosamide in Pediatric Patients With Relapsed and Refractory AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Stanford University 16
Testing effectiveness (Phase 2)UnknownNCT04913922
What this trial is testing

Relatlimab With Nivolumab and 5-Azacytidine for the Treatment of AML

Who this might be right for
Acute Myeloid Leukemia
Ludwig-Maximilians - University of Munich 30
Not applicableStudy completedNCT02194439
What this trial is testing

Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease

Who this might be right for
Graft-Versus-Host Disease
Indiana University 415
Large-scale testing (Phase 3)Not Yet RecruitingNCT07761702
What this trial is testing

Umbilical Cord Blood Consolidation for Older Adults With Intermediate- and High-Risk AML

Who this might be right for
AML (Acute Myelogenous Leukemia)
Shanghai Jiao Tong University School of Medicine 132
Testing effectiveness (Phase 2)Study completedNCT04230239
What this trial is testing

Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid Leukemia

Who this might be right for
Newly Diagnosed Secondary or High Risk AML
PETHEMA Foundation 59
Testing effectiveness (Phase 2)Ended earlyNCT02712905
What this trial is testing

An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumors and Hematologic Malignancy
Incyte Corporation 116
Testing effectiveness (Phase 2)Looking for participantsNCT05092451
What this trial is testing

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

Who this might be right for
B-Cell LymphomaMyelodysplastic Syndromes (MDS)Acute Myeloid Leukemia (AML)+7 more
M.D. Anderson Cancer Center 80
Early research (Phase 1)UnknownNCT03235973
What this trial is testing

Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, Acute
Institut Paoli-Calmettes 29
Testing effectiveness (Phase 2)Study completedNCT00055653
What this trial is testing

Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT04817241
What this trial is testing

Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 5
Next Page